COMMUNIQUÉS West-GlobeNewswire

-
Indiva’s Ontario Cannabis Store Supply Agreement a Testament to Quality -- CFN Media
11/02/2019 - 15:00 -
Alphatec Announces Stay of Court Proceedings in NuVasive Patent Lawsuit
11/02/2019 - 15:00 -
Cerner Leverages AI Solutions to Combat Physician Burnout
11/02/2019 - 15:00 -
Alkaline88: A Well Known Brand with Unmatched Distribution Targets CBD Beverages -- CFN Media
11/02/2019 - 15:00 -
Imprivata Partners with Google Cloud to Enable Single Sign-On Access to Chrome Devices
11/02/2019 - 15:00 -
CohBar Announces the Appointment of Dr. Phyllis Gardner to its Board of Directors
11/02/2019 - 15:00 -
Driven Deliveries Inc. Expands California Cannabis Delivery Platform
11/02/2019 - 14:35 -
Eve & Co Announces Retail Release of Dried Flower
11/02/2019 - 14:32 -
Yield Growth Expanding Product Lines & Distribution Footprint-- CFN Media
11/02/2019 - 14:30 -
Hemispherx Biopharma Announces Commencement of a New 45 Subject Clinical Trial Combining Ampligen and Merck’s Keytruda in the Treatment of Recurrent Ovarian Cancer
11/02/2019 - 14:30 -
Former Procter & Gamble Executive Raj Pudipeddi Joins Align Technology as Senior Vice President and CMO
11/02/2019 - 14:30 -
Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022 at 2019 Angiogenesis, Exudation, and Degeneration Conference
11/02/2019 - 14:30 -
Avalon GloboCare Announces Breakthrough in Identifying Human Angiogenic Exosomes/Extracellular Vesicles (EV) Derived from Endothelial Cells
11/02/2019 - 14:30 -
Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility
11/02/2019 - 14:30 -
PSIQ Forms CannBerry Tek to Develop a Cannabis Genetic Seed Bank to Create Proprietary Cannabis Seed Types and Strains
11/02/2019 - 14:30 -
Advantis Corp. Moves Forward with Plans to Establish Los Angeles Presence, Partners with Statewide Distributor and Manufacturer
11/02/2019 - 14:30 -
AIT Therapeutics Announces Appointment of Robert F. Carey to Board of Directors
11/02/2019 - 14:30 -
Lumere Closes Strategic Growth Capital Funding
11/02/2019 - 14:03 -
Active Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI® (durvalumab) in the upcoming Phase 1b/2 study
11/02/2019 - 14:01
Pages